BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26530461)

  • 1. Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.
    Sato M; Kawana K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Adachi K; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
    Oncol Rep; 2016 Jan; 35(1):391-7. PubMed ID: 26530461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 correlates with stem cell-related transcription factors in cervical cancer.
    Wang H; Cai HB; Chen LL; Zhao WJ; Li P; Wang ZQ; Li Z
    J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):891-897. PubMed ID: 26670442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low P16
    Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.
    Namkoong H; Shin SM; Kim HK; Ha SA; Cho GW; Hur SY; Kim TE; Kim JW
    BMC Cancer; 2006 Mar; 6():74. PubMed ID: 16545136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
    Sneddon JB; Zhen HH; Montgomery K; van de Rijn M; Tward AD; West R; Gladstone H; Chang HY; Morganroth GS; Oro AE; Brown PO
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14842-7. PubMed ID: 17003113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
    Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
    PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization and characterization of cancer stem-like cells in cervical cancer.
    Hayashi K; Tamari K; Ishii H; Konno M; Nishida N; Kawamoto K; Koseki J; Fukusumi T; Kano Y; Nishikawa S; Miyo M; Noguchi K; Ogawa H; Hamabe A; Seo Y; Doki Y; Mori M; Ogawa K
    Int J Oncol; 2014 Dec; 45(6):2468-74. PubMed ID: 25269542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
    Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
    Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
    Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
    BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2.
    Chandimali N; Sun HN; Park YH; Kwon T
    In Vivo; 2020; 34(3):1085-1094. PubMed ID: 32354896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype.
    Myllärniemi M; Vuorinen K; Pulkkinen V; Kankaanranta H; Aine T; Salmenkivi K; Keski-Oja J; Koli K; Kinnula V
    J Pathol; 2008 Mar; 214(4):456-63. PubMed ID: 18072275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes aristolochic acid-induced epithelial-to-mesenchymal transition (EMT) in HK-2 cells.
    Li Y; Wang Z; Wang S; Zhao J; Zhang J; Huang Y
    Toxicology; 2012 Jul; 297(1-3):68-75. PubMed ID: 22525892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
    Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
    Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival.
    Lv Y; Yang L; Wang F
    Med Oncol; 2015 May; 32(5):155. PubMed ID: 25837433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of HIWI and HILI Expression with Cancer Stem Cell Markers in Colorectal Cancer.
    Litwin M; Dubis J; Arczyńska K; Piotrowska A; Frydlewicz A; Karczewski M; Dzięgiel P; Witkiewicz W
    Anticancer Res; 2015 Jun; 35(6):3317-24. PubMed ID: 26026091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells.
    Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Kojima S; Yamashita A; Tomio K; Nagamatsu T; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
    Int J Oncol; 2016 Feb; 48(2):829-35. PubMed ID: 26676222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
    Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
    Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Sox2 in cervical squamous cell carcinoma.
    Yang Z; Pan X; Gao A; Zhu W
    J BUON; 2014; 19(1):203-6. PubMed ID: 24659665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.